22/02/2012 17:46:28

DSV, 436 - Statement of insiders' trading in DSV shares

Related content
20 Jul - 
DSV - H1 2017 analyst conference call
11 May - 
DSV, 647 - Major shareholder announcement
02 May - 
DSV, 646 - Interim Financial Report First quarter 2017
Related debate
10:18 - 
Jeg er med til 380 ;-)
09:09 - 
Trafiktallene er voldsomt stigende. Jeg er overbevist o..
02:22 - 
Godt firma, men alt, alt for dyrt. Er gået udenom, og v..

Stock Exchange Announcement No. 436

Pursuant to the Securities Trading Act notice is hereby given that the

following transactions have been carried out:

Name Jens Bjørn Andersen

---------------------------------------------------------------------

Reason CEO

---------------------------------------------------------------------

Issuer DSV A/S

---------------------------------------------------------------------

ID Code DK0060079531

---------------------------------------------------------------------

Nature of transaction Exercise of share options granted in year 2007

---------------------------------------------------------------------

Trade date 21 February 2012

---------------------------------------------------------------------

Number of shares 25,000

---------------------------------------------------------------------

Market price (DKK) 2,437,500

---------------------------------------------------------------------

Name Jens H. Lund

---------------------------------------------------------------------

Reason CFO

---------------------------------------------------------------------

Issuer DSV A/S

---------------------------------------------------------------------

ID Code DK0060079531

---------------------------------------------------------------------

Nature of transaction Exercise of share options granted in year 2007

---------------------------------------------------------------------

Trade date 21 February 2012

---------------------------------------------------------------------

Number of shares 50,000

---------------------------------------------------------------------

Market price (DKK) 4,875,000

---------------------------------------------------------------------

Name Jens Bjørn Andersen

------------------------------------------

Reason CEO

------------------------------------------

Issuer DSV A/S

------------------------------------------

ID Code DK0060079531

------------------------------------------

Nature of transaction Shares - Sale

------------------------------------------

Trade date 21 February 2012

------------------------------------------

Number of shares 25,000

------------------------------------------

Market price (DKK) 3,190,057

------------------------------------------

Name Jens H. Lund

---------------------------------------

Reason CFO

---------------------------------------

Issuer DSV A/S

---------------------------------------

ID Code DK0060079531

---------------------------------------

Nature of transaction Shares - Sale

---------------------------------------

Trade date 21 February 2012

---------------------------------------

Number of shares 53,235

---------------------------------------

Market price (DKK) 6,791,311

---------------------------------------

Name Jens H. Lund

---------------------------------------

Reason CFO

---------------------------------------

Issuer DSV A/S

---------------------------------------

ID Code DK0060079531

---------------------------------------

Nature of transaction Shares - Sale

---------------------------------------

Trade date 22 February 2012

---------------------------------------

Number of shares 48,135

---------------------------------------

Market price (DKK) 5,986,334

---------------------------------------

Any questions may be addressed to Flemming Ole Nielsen, Investor Relations

Manager, tel. +45 43 20 30 40.

Yours sincerely,

DSV

Flemming Ole Nielsen

Investor Relations Manager

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
23 Jul
DSV
Prøv dog at læse lidt mere og vrøvle lidt mindre. Han skriver jo at det er Nordeas kursmål. Hans ege..
5
25 Jul
DSV
Ser ud til at dsv har været overlæsset, og skal have læsset noget vægt af laddet !
2
02:22
DSV
Godt firma, men alt, alt for dyrt. Er gået udenom, og vil fortsat gå udenom deres aktier.
1
25 Jul
DSV
holder 394 så er der tegningen til en SHS med target 363 - ellers 380    https://invst.ly/4klem   U..
1
25 Jul
DSV
Næh, den tager tilløb til det voksende fragtmarked, world-wide   Har en røvfuld aktier.   BB
1
23 Jul
DSV
Hvis du kikker lidt på de sidste ugers kursudvikling vil du kunne se at DSV fornyligt ret pludselig ..
1

Alliance Trust PLC : Transaction in Own Shares

26/07/2017 07:00:05
26 July 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 25 July 2017 the Company purchased for cancellation 100,000 ordinary shares of 2.5p each at a price of 716.5p per share.  Therefore, the total number of voting rights in the Company is now 352,188,122.    The above figure (352,188,122) may be used by shareholders a..

Alliance Trust PLC : Net Asset Value(s)

25/07/2017 14:52:29
ALLIANCE TRUST PLC                                    At the close of business on Monday 24 July 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 757.0p -       including income, 765.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income,..

Novae Group plc: Holdings in Company

25/07/2017 13:01:24
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
ATOS : First half 2017 results
2
WORLDLINE SA : First half 2017 results
3
Columbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric Medications
4
Outokumpu - Solid profitability despite ferrochrome production challenges, Group adjusted EBITDA at EUR 199 million
5
STMicroelectronics Reports 2017 Second Quarter and First Half Financial Results

Related stock quotes

DSV A/S 399.70 0.4% Stock price increasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 July 2017 09:49:03
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170720.2 - EUROWEB4 - 2017-07-26 10:49:03 - 2017-07-26 09:49:03 - 1000 - Website: OKAY